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According to Wilson (1), ‘‘. . . any plausible unifying
theory that seeks to marry longevity, functional disability,
and health perception must involve political, social, cultural,
psychological, and economic factors.’’ On the contrary,
Fries (2) states: ‘‘A general theory of biological aging . . .
needs to precede a general theory of population aging,
which then could be derived from it, and inconsistencies and
contradictions explained.’’ Even, if the latter seems to be
tailor-made to answer the former, and vice versa, it is
significant that they were both comments on our article,
which proposes broad outlines for a general theory on
population aging. Their independent suggestions that we did
not fully consider the social and political factors as well as
the biological factors may indeed indicate that we have
achieved a balanced approach.
Wilson and Fries are 2 of the 13 scholars, biologists,
demographers, epidemiologists, and clinicians, including
several geriatricians, who reacted to our proposal, providing
together a reasonable sample of gerontological thinking (1–
13). First, we thank all of them for their participation. Their
pleasure was obvious and their contributions were, for the
most part, positive. We have really enjoyed beginning this
debate, although the number of points raised cannot all be
answered here. We have therefore selected a few to begin
with, and apologize to the remainder. We acknowledge that,
at present, our article lacks depth and detail, as underlined
by Carnes and Bernard (4), but, again, our aim was to
propose the main outline for a general theory of population
aging and to open the debate rather than complete it.
Proposing a General Theory of Population Aging
We disagree with the opinion that a general theory of
(individual) biological aging needs to precede a general
theory of population aging. The survival and longevity of
any individual within human populations depends on a long
and complex interplay between biological factors and the
social organization of the group (i.e., the population), its
level of economic development, including biological
and medical technologies, and its ability to transform its
environment. Taking the individual from the group or the
population from the environment is meaningless when
studying aging (14). Since the work of Strehler and Mildvan
(15), we now have a greater understanding of the plasticity
of aging (16,17). Most of us today understand that health or
longevity, at the individual or population levels, is the result
of several factors including genes, environment, and some
chance or chaos (18). There is no longer a belief that the
potential maximum life span is approximately 100 or 110
years, or that there are no more centenarians today than in
ancient times (19–21).
Guralnik (9) provides the best summary of our proposed
outline, noting that, through time, ‘‘there may be a circling
back, where, first sicker people survive into old age and
disability rises, then the number of years lived with disability
decreases as new cohorts of healthier people enter old age, but
finally, the number of years lived with disability rises again
when the average age of death goes so high that many people
spend their last years at advanced old age burdened by
multiple chronic diseases and frailty.’’ Obviously, this itself
could form the basis of a theory. Indeed, several commenta-
tors propose refinements to our proposal. Deeg (5), for
instance, wishes to complement the global theory with
something more local and gives three arguments in support:
local forces, period factors, and initial levels of disability.
However, when proposing a general theory of population
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aging, we need to identify the strongest trends behind local or
period factors. For example, when identifying long-term
mortality improvement, we cannot average past years, mixing
poor and good years. Looking only at the good years
identifies a more fundamental trend, largely hidden by the
fluctuations of the past, and this is the approach followed by
Oeppen and Vaupel when studying the record life expectan-
cies to reveal the most fundamental trend in life expectancy
increase (22). The mortality crisis in Russia and other Eastern
European countries is an historical event and, as such, belongs
to the fluctuations of the past. A general theory should help to
identify the major trends behind local or historical events, not
the opposite. Nevertheless, the contributions of Deeg and
others provide us with thought.
In the same vein, Wilson (1) stresses the role of caring in
enhancing longevity as opposed to the more usual view of
blaming premature death on disease and extrinsic factors.
Carnes and Bernard (4) stress the role of the initial level of
aging, noting that, ‘‘In the early stages of population aging,
the expected good health of the relatively younger old
people in the emerging postreproductive population would
favor the compression of morbidity hypothesis,’’ and that
later ‘‘there will be a tension between the aging and
heterogeneity-driven expansion of morbidity and the bio-
medical and societal efforts to mitigate the morbidity
consequences of aging.’’ Deeg (5) also emphasizes the role
of the initial level of disability, noting that compression is
more likely when there is room, that is, when disability
levels are high. Using the converse idea, Deeg (5) suggests
that the disability increase observed in Australia might be
because the disability level was initially low. In their
analysis of the Australian data, Davis and colleagues
derived their estimates from the 1993 and 1998 surveys
using definitions consistent with the 1981 and 1988 survey
screening questions (23). Therefore, changes in definitions
cannot explain the increase in disability observed in
this country as had been suggested by Caplan and Harper
(3). A change in societal attitudes, earlier diagnosis of
chronic conditions, and better treatment are common to all
Western countries and are not specific to Australia. All these
comments reinforce our outline. With socioeconomic
development comes improvements in care that increase
survival. In the early stages of population aging, the
relatively young age of the older population and the initial
high level of disability would favor the compression of
morbidity hypothesis, and this could partly explain how
a phase of expansion can be followed by a phase of
compression and vice versa.
Measuring Disability and Interpreting Change
Over Time
Almost all of the commentators mention the difficulty in
measuring disability and interpreting change over time.
They stress that chronic diseases, impaired functions,
disability, or frailty are different concepts and that there
are many questions aimed at measuring disability (3,7,9,12).
Ignoring differences and other features in survey design may
lead to apparent inconsistencies in disability trends, as
illustrated by the recent debate devoted to the ‘‘true’’ trend
in cognitive decline (24–26). Guralnik (9) stresses that
different subgroups and cultures may differentially interpret
questions on their disability. We agree that REVES (Re´seau
sur l’Esperance de Vie en Sante´), the International Network
on Health Expectancy and the Disability Process, was one of
the first significant enterprises that aimed to systematically
disentangle all of these issues at an international level (27–
29). As noted by Guralnik (9), objective physical perfor-
mance assessment through physical tests is promising to
define an underlying level of functional status against which
we can calibrate self-report of functional limitations and
disability—an approach that might offer new avenues to
further enhance health data harmonization, especially in
different cultures. On the other hand, we must remember
that the evidence showing that perception of health status is
a more reliable predictor of health outcomes than many
objective parameters (1). In other words, functional
assessment, itself important to clinicians for achieving
patient goals, should complement, but not replace, self-
report (6).
Compression of Morbidity and Compression
of Disability
Not surprisingly, many commentators focus on the
compression of disability that is generally expected over
the coming years, with changes in the built environment and
advances in technology and assistant devices being the main
contributors by easing the performance of daily activities
(7,12). Goodwin (8) observes ‘‘if we want to picture the 4
million [American] centenarians in 2050, we should think of
our current patients in their late 80s.’’ But this is exactly
what we don’t know! We don’t know if disability is largely
avoidable until very close to death, whatever the ages
reached. These optimistic scenarios will only occur if the
postponement of disability outpaces that of death (9).
Guralnik (9) also notes that if future populations look more
like the current [United States] high education population,
they would live longer and have higher active life
expectancy, although their total number of person-years of
disability could be higher. This is a recurring theme found
by the REVES network when comparing male and female
life and active life expectancies (30). So how do we measure
our success if an increase in active life expectancy can
accompany an absolute increase in the number of old people
with disability? We agree with Guralnik (9) that, to answer
this question, we need to develop a new epidemiology of
extreme longevity, particularly addressing quality of life.
Compression of disability can be carefully distinguished
from compression of morbidity (12). The prevalence of
reported morbidity can increase due to earlier diagnosis
and longer survival while the prevalence of disability can
decrease due to environmental modifications. In between
these, the prevalence of functional limitations takes an
increasingly important role in helping to assess whether the
excess in current reported morbidity, for example, due to
earlier diagnosis, is less severe than that reported in the past.
Although Fries (2) remains the champion of the theory of
‘‘compression of morbidity’’ in its original version, others
are now making refinements, for example, proposing that
compression occurs when active life expectancy increases
faster than the total life expectancy. Therefore, a limit to life
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expectancy increases is no longer a necessary condition for
the occurrence of ‘‘compression’’ (31). Distinguishing
morbidity, functional abilities, and disability enriches the
concept of compression because an expansion of morbidity
will probably occur in parallel with a compression of
disability as discussed by Mor and Perls (12). So, the true
question is about functional abilities and the way to measure
them. Can we postpone physical, sensory, and cognitive
functional limitations to the same extent that we postpone
deaths? How much can we prevent diseases and reduce
medical expanses?
What can be the impact of unfavorable trends in
children’s health, such as the obesity epidemic? Deeg
(5), for instance, wonders whether the current advances in
neonatal care of preterm births or increased use of in vitro
fertilization can play against life expectancy increase. As
noted by Carnes and Bernard (4), it is almost impossible to
project how current changes in the health of younger
populations may impact overall longevity. If the prevalence
of childhood obesity on the one hand is increasing, several
fatal diseases are becoming curable. On the other hand, if we
give 70 years to the current teenagers for entering the oldest-
old age group, we can see that the potential impact of
childhood obesity will not be sensitive before long.
Future Prospects on Human Longevity
Wilson (1) considers that the increase in life span is not
as well established as the increase in life expectancy,
and wonders whether the increase in longevity is mere
conjecture. In fact, two means have been proposed for
measuring the life span and its increase: 1) the maximum
life span and indicators such as the maximum reported age
at death, and 2) the late mode of the ages at death measuring
the most typical life span under a given mortality regime
(32). Both maximum and mean life spans are clearly
increasing in countries with good-quality data (29,32–36).
Therefore, the best available evidence is in favor of an
increase in longevity. We agree that care is needed until
there are more confirmatory studies. However, we cannot
maintain that this apparent increase will last forever nor
can we accept, like Fries (2), to a ‘‘point of paradox,’’ which
would prevent life expectancy exceeding 87 years. We must
keep an open mind and rigorously examine the empirical
data and available evidence on the plasticity of aging.
We certainly do not know the frequency of centenarians
in our distant past, as mentioned by Olshansky (13), in
Rome or Athens for instance, or whether the maximum age
at death has ever increased during the second millennium,
but we do have enough historical data from the 16th
century to maintain that octogenarians were rare in the 17th
century (16) and centenarians probably exceptional before
the 19th century (37). The previous models of population
aging totally overlooked the emergence of new age groups
through the epidemiological transition, and therefore we
cannot explain its dynamics. Again, a theory must
reconcile past trends and anticipate the future, aiding us
to build scenarios, even those feared, such as the
accumulation of extremely old frail persons, and thereby
allowing the development of strategies to ameliorate the
effects (38).
There is increasing evidence that family is an important
dimension of longevity as underlined by Mor and Perls (12).
Siblings not only share genes, but also share a number of
environments: family, social group, and region, all playing
a role in observed longevity. In epidemiology, socio-
economic status is a key predictor of mortality. We need
more studies to understand the degree to which extreme
longevity is explained by shared family factors: sharing
genes, belonging to the better off, or living in a favored
region. The probability of becoming a centenarian is
presently increasing rapidly, and this makes it more difficult
to compare the meaning of being a centenarian today with,
say, in 1990. More and more centenarians should display
fewer and fewer exceptional characteristics.
Introducing Frailty
Whatever the life course morbidity profile of centenar-
ians, ‘‘survivors,’’ ‘‘delayers,’’ or ‘‘escapers’’ (39), whatever
their health status was when they were 90 years old (40),
almost all centenarians are dependent at least in instrumental
activities of daily living (41).
Again, the clear critiques of Fries (2) and Wilson (1)
about the way we present frailty encourage us to consider
whether we have a comprehensive understanding of this
phenomenon. We do not equate frailty with disability.
A person with a disability can be robust and live within
the community, independently or not, but without specific
health and mortality risks. Yes, we equate frailty with
increased risk of disability (42) and death (43,44). The
concept of frailty is not new. What is new is the emergence
of frail persons. Previously frail persons were dying too fast
to accumulate. While no operational definition of frailty still
exists, frailty appears in gerontology as a fourth dimension
of the individual health status. It is conceptually differ-
ent from age, comorbidity, and disability even if it is
statistically associated to these three other dimensions.
Frailty is the loss of the ability to cope with daily stress,
whatever the stress (social events, passage of seasons, minor
diseases) and whatever the cause (loss of reserves or loss of
the ability to mobilize and use them).
Only the provision of specific shelters and protecting the
oldest-old from most of their daily stress allows them to
survive. The built environment, confinement within the
family, the development of modern nursing homes, and the
provision of essential nursing services such as providing
meals, all help to explain the current accumulation of frail
persons. The 2003 summer heat wave in Europe and the
oldest-old hecatomb following the lack of air-conditioning
in most nursing homes, illustrate perfectly well our point.
Wilson claims that ‘‘the concept of frailty as an embodiment
of reduced functional reserves is an inevitable precedent
of nonaccidental death at any age.’’ This is correct, but
at younger ages, nonaccidental deaths are due to lethal
diseases such as cancers or heart diseases, which do not
allow frail persons to accumulate. The combination of the
absence of clear life-threatening diseases and a protective
environment explain the accumulation of frail persons
among the oldest-old. The causes of death for the
oldest-old are poorly understood, and their death certificates
contain mainly imprecise causes of death (45).
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From Theory to Action
Kane (11) warns, ‘‘The hurricane is coming.’’ Of course,
the baby boomers will eventually reach an age, say 85 years,
where the prevalence of disability and frailty becomes
significant, but this will not occur before 2030 and 15 more
years will pass before the nonagenarian group will be made
solely of baby boomers. The current emergence of
extremely old persons is related more to those born in the
first part of the 20th century. It is therefore even more urgent
that we understand the relationships between increased
longevity and the health of the oldest-old in its three main
components: morbidity, functional limitations, and disabil-
ity, taking into account all possible mediator factors. Indeed,
Jagger (10) states that the ‘‘purpose of a general theory on
population aging is not only to describe where we are in the
process but also to learn how we might ‘interfere’ with the
process.’’ She lists all the possible factors, extraindividual
and intraindividual, that interfere with the disablement
process and that might delay it. Most researchers emphasize
the necessity of creating common measures of health such
as the interRAI for long-term care services (46) or the
EuroREVES package at the population level (29). Several
agree on the need for a regular International Aging Survey
‘‘using truly comparable measures on a carefully selected set
of countries, chosen for their similarity and variability
across a range of the important factors’’ (10).
Provocatively, Wilson (1) claims that ‘‘[s]tudying global
aging from the scientific perspective’’ is not an interesting
venture for the gerontological community, and chooses to
conclude with a quotation by Isaac Asimov that ‘‘. . . life is
pleasant, death is peaceful, it’s the transition that troubles.’’
She adds that geriatrics is concerned with this transition.
However, we feel that geriatrics, specifically gerontology,
should be as much about successful or healthy aging and
postponement of frailty or disability as about palliative care.
The quality of years lived is probably the most important
criteria by which to measure our success: quality of the
active years but also quality of the years lived with disability
and of the years lived as a frail person, and, of course,
quality of the last years and days of life (47). However, we
should keep in mind that giving priority to quality of life and
providing the best available care each time it is necessary
will probably further increase longevity and the number of
more extremely old persons.
At the end of this discussion, we can refine our initial
proposal, adding more details about the plasticity of aging
and mortality to environment, including local conditions,
general housing conditions, and the importance of caring. It
seems, however, that nobody has really disputed the logic of
our proposal and the challenge that constitutes the
emergence and rapid accumulation of extremely old
persons. Action starts with information and data collection.
Obviously, one of the first steps taken should be the
development of reliable health measures allowing us to
monitor functional health status, the level of frailty, and the
quality of life of the oldest-old. The implementation of an
International Aging Survey would contribute greatly.
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